Bacterial inclusion bodies are nanostructured protein materials produced in bacteria with biomedical applications such as protein drug release and biofunctional topographies. However, many enzymes with possible biomedical or...
Protein misfolding and aggregation is associated with numerous degenerative human disorders such as type-II-diabetes or Alzheimer’s disease. In previous research we identifieda threshold abovewhich a cell began to actively accumulate protein aggregates. The data obtained in this new...
Inclusion bodies or amyloids are nanostructured protein aggregates produced inside a cell, frequent in certain bacteria, and with interesting biomedical applications such as drug protein delivery. Until now, the use of inclusion bodies was limited by the presence of own toxins from the...
Researchers of the Nanobiology Unit from the UAB Institute of Biotechnology and Biomedicine, led by Antonio Villaverde, have produced an alternative to the use of viruses in gene therapy.The researchers synthesised nanoparticles which act as artificial...
Kostas Kostarelos is Professor of Nanomedicine at the University of Manchester and Honorary Professor at the University College of London (UK) and is founding editor of the journal Nanomedicine. He recently advised the company PlayGen to develop a video game on nanomedicine in order to use this technology as a tool...
A group of researchers led by the Institute of Biotechnology and Biomedicine (IBB) and UAB have achieved to quantify with precision the effect of protein aggregation on cell aging processes using as models the Escherichia coli bacteria and the molecule which triggers Alzheimer's disease. Scientists...
